Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder
暂无分享,去创建一个
Randy D. Blakely | Mark A. Stein | R. Shelton | R. Blakely | M. Stein | M. Mazei-Robison | Richard C. Shelton | R. Couch | Michelle S. Mazei-Robison | R. Steven Couch
[1] M. Nöthen,et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder , 2001, Biological Psychiatry.
[2] M. DelBello,et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. , 2002, Journal of child and adolescent psychopharmacology.
[3] Chan-Hyung Kim,et al. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[4] M A Geyer,et al. Prepulse Inhibition Deficits and Perseverative Motor Patterns in Dopamine Transporter Knock-Out Mice: Differential Effects of D1 and D2 Receptor Antagonists , 2001, The Journal of Neuroscience.
[5] E H Cook,et al. Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations , 2000, Molecular Psychiatry.
[6] D. Weinberger,et al. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia , 2004, Trends in Neurosciences.
[7] Jonathan C. Cohen,et al. Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.
[8] S. Purcell,et al. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample , 2003, Molecular Psychiatry.
[9] K. Chang,et al. Characterization of children of bipolar parents by parent report CBCL. , 2002, Journal of psychiatric research.
[10] R. Joober,et al. Dopamine genes and attention-deficit hyperactivity disorder: a review. , 2003, Journal of psychiatry & neuroscience : JPN.
[11] A. Heath,et al. No association of the dopamine transporter gene 3' VNTR polymorphism with ADHD subtypes in a population sample of twins. , 2001, American journal of medical genetics.
[12] Darin D Dougherty,et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder , 1999, The Lancet.
[13] D. Mennin,et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[14] J. Gelernter,et al. Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)). , 1998, Genomics.
[15] M. Gill,et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci , 2003, Molecular Psychiatry.
[16] Donald C. Cooper,et al. Loss of autoreceptor functions in mice lacking the dopamine transporter , 1999, Nature Neuroscience.
[17] M. Gill,et al. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.
[18] S. Cichon,et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) , 2000, Molecular Psychiatry.
[19] I. Waldman,et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. , 1998, American journal of human genetics.
[20] T. Ketter,et al. Psychiatric phenomenology of child and adolescent bipolar offspring. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.
[21] F. Bloom,et al. The Biochemical Basis of Neuropharmacology , 1976 .
[22] X Li,et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.
[23] M. Gill,et al. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.
[24] B. Greenberg,et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype , 2003, Molecular Psychiatry.
[25] S. Strakowski,et al. The comorbidity of attention-deficit hyperactivity disorder in adolescent mania: potential diagnostic and treatment implications. , 1995, Psychopharmacology bulletin.
[26] Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.
[27] D. Comings,et al. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[28] S. Fuke,et al. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression , 2001, The Pharmacogenomics Journal.
[29] D. Mennin,et al. Is comorbidity with ADHD a marker for juvenile-onset mania? , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[30] D. Mennin,et al. A pilot family study of childhood-onset mania. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[31] N. Nelson,et al. The Family of Na+/Cl− Neurotransmitter Transporters , 1998, Journal of neurochemistry.
[32] Yu-Shin Ding,et al. Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain , 2001, The Journal of Neuroscience.
[33] P. Ambrosini. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.
[34] J. Swanson,et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder , 2003, Molecular Psychiatry.
[35] R. Gainetdinov,et al. Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.
[36] A. Thapar,et al. Genetic basis of attention deficit and hyperactivity , 1999, British Journal of Psychiatry.
[37] I. Craig,et al. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. , 2002, American journal of medical genetics.
[38] M. Caron,et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.
[39] E. Bowman,et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. , 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[40] M. Owen,et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder , 2000, Molecular Psychiatry.
[41] John P Seibyl,et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. , 2002, The American journal of psychiatry.
[42] P. Keck,et al. Segmental linkage disequilibrium within the dopamine transporter gene , 2002, Molecular Psychiatry.
[43] E D Levin,et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.
[44] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[45] W. Wetsel,et al. Anterior Pituitary Hypoplasia and Dwarfism in Mice Lacking the Dopamine Transporter , 1997, Neuron.
[46] K.,et al. Psychiatric and Medical Comorbidities of Bipolar Disorder , 2005, Psychosomatic medicine.
[47] B. Madras,et al. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression , 2002, Molecular Psychiatry.
[48] George R. Uhl,et al. D2 dopamine receptor Gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers , 1996, Biological Psychiatry.
[49] S. Nelson,et al. No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. , 1999, Psychiatric genetics.
[50] A Second Generation Catecholamine Hypothesis , 1982 .
[51] R. Rodriguiz,et al. Aberrant responses in social interaction of dopamine transporter knockout mice , 2004, Behavioural Brain Research.
[52] J. Gelernter,et al. Genetic Association between Dopamine Transporter Protein Alleles and Cocaine-Induced Paranoia , 1994, Neuropsychopharmacology.
[53] Zhaowei Liu,et al. Integrated platform for detection of DNA sequence variants using capillary array electrophoresis , 2002, Electrophoresis.
[54] A. Singleton,et al. Genes and parkinsonism , 2003, The Lancet Neurology.
[55] R. Blakely,et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.
[56] B. Giros,et al. Behavioral Disturbances Associated with Hyperdopaminergia in Dopamine-transporter Knockout Mice , 2022 .
[57] N J Cox,et al. Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.
[58] K. Tatsch,et al. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment , 2000, European Journal of Nuclear Medicine.
[59] I. Waldman,et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. , 2003, Pediatrics.
[60] C. Cusin,et al. Dopamine transporter haplotype and attention-deficit hyperactivity disorder , 2005, Molecular Psychiatry.
[61] Klaus Tatsch,et al. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography , 2000, Neuroscience Letters.
[62] J. Mill,et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples , 2001, Molecular Psychiatry.
[63] David J. States,et al. QGB: Combined Use of Sequence Similarity and Codon Bias for Coding Region Identification , 1994, J. Comput. Biol..
[64] R. Blakely,et al. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala , 2005, Neuropharmacology.
[65] M. Geyer,et al. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system , 2003, Biological Psychiatry.
[66] D. Blakely,et al. Population genetic study of the human dopamine transporter gene (DAT1) , 1995, Genetic epidemiology.
[67] N. Ryan,et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[68] E. Cook,et al. Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD , 2005, Neuropsychopharmacology.
[69] D. Diehl,et al. The role of dopamine in mood disorders. , 1992, Comprehensive psychiatry.
[70] R. Post,et al. A dopaminergic mechanism in mania. , 1976, The American journal of psychiatry.
[71] A. Carlsson. Perspectives on the discovery of central monoaminergic neurotransmission. , 1987, Annual review of neuroscience.